Shiga toxin producing Escherichia coli (STEC) infection causes diarrhea, bloody diarrhea and in severe cases, patients develop Hemolytic Uremic Syndrome (HUS) and central nervous system (CNS) impairment. STEC induced neuronal disabilities includes a broad spectrum of symptoms as cortical blindness, poor fine-motor coordination, seizures and changes in consciousness including coma. Importantly, CNS manifestations often associate with mortality or severe sequelae. STEC produce Shiga toxins 1 and 2 (Stx1 and Stx2); among them, Stx2 is more potent as a cause of severe HUS and CNS impairment. However, precise mechanisms of Shiga toxin induced CNS impairment are not yet clear. I propose to reveal the mechanisms of Shiga toxin action in the CNS by using in vitro neuron-astrocytic cell culture and in vivo with the Stx2 induced hindlimb paralysis murine model.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
High Priority, Short Term Project Award (R56)
Project #
1R56AI090144-01A1
Application #
8288961
Study Section
Host Interactions with Bacterial Pathogens Study Section (HIBP)
Program Officer
Baqar, Shahida
Project Start
2011-07-05
Project End
2014-06-30
Budget Start
2011-07-05
Budget End
2014-06-30
Support Year
1
Fiscal Year
2011
Total Cost
$375,000
Indirect Cost
Name
University of Maryland Baltimore
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
188435911
City
Baltimore
State
MD
Country
United States
Zip Code
21201
Obata, Fumiko; Obrig, Tom (2014) Role of Shiga/Vero toxins in pathogenesis. Microbiol Spectr 2: